Confluence Life Sciences, Inc. — Form D
Confluence Life Sciences, Inc. of SAINT LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2016-04-19. The offering totals $5.4M, of which $4.8M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2016-04-19
- Form: D
- Accession: 0001540502-16-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.4M
- Amount sold: $4.8M
- Remaining: $605K
- Minimum investment: $1
- Investors: 16
- Date of first sale: 2016-04-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-261658
Issuer
- Name: Confluence Life Sciences, Inc.
- CIK: 0001540502
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 4320 FOREST PARK AVE., SAINT LOUIS, MO, 63108
- Phone: 314-932-4032
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Charles Bolten | Director | St. Louis, MO |
| Daniel Janiak | Director | St. Louis, MO |
| Joseph Monahan | Director | St. Louis, MO |
| Kyparissia Sirinakis | Director | Charlottesville, VA |
| Thomas Smart | Director | St. Louis, MO |
| Walter Smith | Director | St. Louis, MO |
| Jennifer Bohnert | Executive Officer | St. Louis, MO |
| Joseph Monahan | Executive Officer | St. Louis, MO |
| Walter Smith | Executive Officer | St. Louis, MO |
| Robert Beardsley | Executive Officer | St. Louis, MO |
| Dan Broderick | Director | St. Louis, MO |
| Michael Kuo | Director | St. Louis, MO |
Other filings by this issuer (1)
More